Health Care & Life Sciences » Pharmaceuticals | Kissei Pharmaceutical Co. Ltd.

Kissei Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
13,400
10,466
11,136
10,116
11,697
7,121
Depreciation, Depletion & Amortization
2,190
2,203
2,343
2,370
2,492
2,607
Other Funds
3,198
6,599
2,992
4,192
3,217
3,911
Funds from Operations
12,392
6,070
10,487
8,294
10,973
5,816
Changes in Working Capital
447
597
4,724
1,851
2,128
530
Net Operating Cash Flow
11,945
6,667
5,763
6,443
8,845
6,346
Capital Expenditures
2,108
2,365
2,281
2,539
2,523
Sale of Fixed Assets & Businesses
72
39
1
28
20
Purchase/Sale of Investments
227
915
2,051
2,224
556
Net Investing Cash Flow
2,315
3,168
5,685
4,671
2,959
Cash Dividends Paid - Total
2,007
2,110
2,103
2,201
2,270
Issuance/Reduction of Debt, Net
294
65
41
85
114
Net Financing Cash Flow
2,304
10,081
2,146
3,766
6,621
Net Change in Cash
7,313
6,122
2,047
1,996
737
Free Cash Flow
10,036
4,693
3,785
5,242
6,978
Other Sources
168
192
162
173
165
Change in Capital Stock
3
7,906
2
1,649
4,464
Exchange Rate Effect
13
460
21
-
2
Other Uses
220
119
1,516
111
65
Miscellaneous Funds
-
-
-
2
-

About Kissei Pharmaceutical Co.

View Profile
Address
19-48 Yoshino
Matsumoto 399
Japan
Employees -
Website http://www.kissei.co.jp
Updated 07/08/2019
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Ethical Pharmaceuticals and Others. The Ethical Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.